Clinical trial
Effect of Inhalation Administration of Ozone Plasma on Lung Function and Inflammatory Parameters in Patients With Pulmonary Sequelae Associated With Coronavirus 19 Infection (SARS-COV-2)
NCT05089305 is registered in ClinicalTrials.gov with Centro Universitario de Ciencias de la Salud, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Inhalation Administration of Ozone Plasma on Lung Function and Inflammatory Parameters in Patients With Pulmonary Sequelae Associated With Coronavirus 19 Infection (SARS-COV-2)
- Lead sponsor
- Centro Universitario de Ciencias de la Salud, Mexico
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 4, 2021
- Completion date
- December 21, 2022
- Enrollment
- 35 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.